P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844908.44691.86 |
| _version_ | 1797287886540767232 |
|---|---|
| author | B. J. Ball G. Borthakur A. Stein K. W. Chan D. Thai E. M. Stein |
| author_facet | B. J. Ball G. Borthakur A. Stein K. W. Chan D. Thai E. M. Stein |
| author_sort | B. J. Ball |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:19Z |
| format | Article |
| id | doaj.art-33d4d63a0e504deabbc927bfbe275e31 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:19Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-33d4d63a0e504deabbc927bfbe275e312024-03-02T03:51:50ZengWileyHemaSphere2572-92412022-06-01640440510.1097/01.HS9.0000844908.44691.86202206003-00404P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51B. J. Ball0G. Borthakur1A. Stein2K. W. Chan3D. Thai4E. M. Stein51 Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte2 Leukemia, MD Anderson Cancer Center, Houston1 Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte3 BioTheryx, San Diego3 BioTheryx, San Diego4 Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000844908.44691.86 |
| spellingShingle | B. J. Ball G. Borthakur A. Stein K. W. Chan D. Thai E. M. Stein P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51 HemaSphere |
| title | P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51 |
| title_full | P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51 |
| title_fullStr | P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51 |
| title_full_unstemmed | P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51 |
| title_short | P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51 |
| title_sort | p505 safety and efficacy of casein kinase 1α and cyclin dependent kinase 7 9 inhibition in patients with relapsed or refractory aml a phase 1 first in human study of btx a51 |
| url | http://journals.lww.com/10.1097/01.HS9.0000844908.44691.86 |
| work_keys_str_mv | AT bjball p505safetyandefficacyofcaseinkinase1aandcyclindependentkinase79inhibitioninpatientswithrelapsedorrefractoryamlaphase1firstinhumanstudyofbtxa51 AT gborthakur p505safetyandefficacyofcaseinkinase1aandcyclindependentkinase79inhibitioninpatientswithrelapsedorrefractoryamlaphase1firstinhumanstudyofbtxa51 AT astein p505safetyandefficacyofcaseinkinase1aandcyclindependentkinase79inhibitioninpatientswithrelapsedorrefractoryamlaphase1firstinhumanstudyofbtxa51 AT kwchan p505safetyandefficacyofcaseinkinase1aandcyclindependentkinase79inhibitioninpatientswithrelapsedorrefractoryamlaphase1firstinhumanstudyofbtxa51 AT dthai p505safetyandefficacyofcaseinkinase1aandcyclindependentkinase79inhibitioninpatientswithrelapsedorrefractoryamlaphase1firstinhumanstudyofbtxa51 AT emstein p505safetyandefficacyofcaseinkinase1aandcyclindependentkinase79inhibitioninpatientswithrelapsedorrefractoryamlaphase1firstinhumanstudyofbtxa51 |